BOSS Zhipin Repurchases 748,460 Shares; Total Repurchases Amount to Over RMB480 Million in 2026

3/26/26 6:30:00 AM ET

Computer Software: Programming Data Processing

Technology

Get the next $BZ alert in real time by email

BEIJING, March 26, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED ("BOSS Zhipin" or the "Company") (NASDAQ:BZ, HK: 2076)) today announced the continued execution of its share repurchase program, utilizing around RMB34.4 million to repurchase 748,460 ordinary shares on March 25. Year-to-date in 2026, the Company has deployed over RMB480 million toward share repurchases. This move underscores the Company's ongoing commitment to shareholder returns.

CONTACT:
PIACENTE·FINANCIAL COMMUNICATIONS
[email protected]

Get the next $BZ alert in real time by email

Crush Q1 2026 with the Best AI Superconnector

Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

AI-Powered Inbox

Context-aware email replies

Strategic Decision Support

Get Started with Standout.work

Recent Analyst Ratings for
$BZ

Date	Price Target	Rating	Analyst
8/21/2025	$26.00	Neutral → Buy	UBS
12/9/2024	$15.00	Outperform → Mkt Perform	Bernstein
11/18/2024	$18.00	Outperform	CLSA
7/25/2024		Buy → Neutral	Daiwa Securities
5/24/2024	$30.00	Buy	HSBC Securities
3/13/2024	$17.00 → $25.00	Neutral → Buy	New Street
3/12/2024		Neutral → Outperform	Macquarie
12/20/2023	$17.00	Neutral	New Street

More analyst ratings

$BZ
Press Releases

Fastest customizable press release news feed in the world

View All

BOSS Zhipin Repurchases 748,460 Shares; Total Repurchases Amount to Over RMB480 Million in 2026

3/26/26 6:30:00 AM ET

$BZ

Computer Software: Programming Data Processing

Technology

BOSS Zhipin Continues Share Repurchase Program; Cumulative Repurchases Reach Nearly RMB450 Million in FY26

BEIJING, March 25, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED ("BOSS Zhipin" or the "Company") (NASDAQ:BZ, HK: 2076)) today announced the continued execution of its share repurchase program, utilizing around RMB34.4 million to repurchase 748,552 ordinary shares on March 24. Year-to-date in 2026, the Company has deployed nearly RMB450 million toward share repurchases. This move underscores the Company's ongoing commitment to shareholder returns. On March 18, 2026, the Company's board of directors (the "Board") approved amendments to the existing share repurchase program, increasing the total authorization under the program to repurchase up to US$400 million of the Company's shares (including

3/25/26 6:30:00 AM ET

$BZ

Computer Software: Programming Data Processing

Technology

BOSS Zhipin Continues Share Repurchase Program, Reinforcing Commitment to Shareholder Returns

BEIJING, March 23, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED ("BOSS Zhipin" or the "Company") (NASDAQ:BZ, HK: 2076)) today announced the continued execution of its share repurchase program, utilizing around RMB34.5 million to repurchase 733,918 ordinary shares on March 20. Year-to-date in 2026, the Company has deployed around RMB380 million toward share repurchases. This move underscores the Company's ongoing commitment to shareholder returns. On March 18, 2026, the Company's board of directors (the "Board") approved amendments to the existing share repurchase program, increasing the total authorization under the program to repurchase up to US$400 million of the Company's shares (including

3/23/26 4:30:00 AM ET

$BZ

Computer Software: Programming Data Processing

Technology

$BZ
Financials

Live finance-specific insights

View All

BOSS Zhipin Continues Share Repurchase Program; Cumulative Repurchases Reach Nearly RMB450 Million in FY26

3/25/26 6:30:00 AM ET

$BZ

Computer Software: Programming Data Processing

Technology

BOSS Zhipin Continues Share Repurchase Program, Reinforcing Commitment to Shareholder Returns

3/23/26 4:30:00 AM ET

$BZ

Computer Software: Programming Data Processing

Technology

KANZHUN LIMITED Announces Shareholder Return Target Through Dividend Distribution and Extension and Upsizing of Share Repurchase Program

BEIJING, March 18, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (the "Company") today announced that its board of directors (the "Board") has approved an amendment to its existing share repurchase program and a shareholder return target. On March 18, 2026, the Board approved amendments to the existing share repurchase program, increasing the total authorization under the program to repurchase up to US$400 million of the Company's shares (including ADSs) over the extended term of the program through August 28, 2027, as a sign of confidence in the Company's continued growth in the future. In August 2025, the Company approved an annual dividend policy (the "Dividend Policy"), pursuant to which

3/18/26 7:50:00 AM ET

$BZ

Computer Software: Programming Data Processing

Technology

$BZ
Leadership Updates

Live Leadership Updates

View All

KANZHUN LIMITED Announces Board Changes and Appointment of President

BEIJING, Aug. 20, 2025 (GLOBE NEWSWIRE) -- KANZHUN LIMITED ("BOSS Zhipin" or the "Company") (NASDAQ:BZ, HKEX: 2076)), a leading online recruitment platform in China, today announced that Ms. Mengyuan Dong has resigned as an independent non-executive director of the Company in order to devote more time to her other personal business commitments, effective on August 20, 2025. In addition, with effect from August 20, 2025, Ms. Hongyu Liu, an independent non-executive director and a member of the nomination committee has been appointed as the chairman of the audit committee and a member of the corporate governance committee. Mr. Yan Li, an independent non-executive director, the chairman of t

8/20/25 7:10:01 AM ET

$BZ

Computer Software: Programming Data Processing

Technology

Allink Biotherapeutics Raises $42M Series A Financing to Accelerate Global Development of Bispecific Antibody and ADC Pipeline

The series A investment round secures resources for advancing global Phase I/II clinical programs and orchestrating the company's global footprint expansion. SHANGHAI, Nov. 28, 2024 /PRNewswire/ -- Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation bispecific antibody and antibody-drug conjugate (ADC) therapeutics, today announced the successful completion of a $42 million Series A financing. The financing round was led by Lanchi Ventures, a preeminent global early-stage technology investor known for backing breakthrough innovations, with participation from an elite syndicate of new investors including Yuanbio Venture Capital, Legend Capital and C&D Eme

11/28/24 8:06:00 AM ET

$BZ

$HUYA

$LI

Computer Software: Programming Data Processing

Technology

Auto Manufacturing

Industrials

Kanzhun Limited (Nasdaq: BZ) Rings The Nasdaq Stock Market Opening Bell

BEIJING, June 17, 2024 (GLOBE NEWSWIRE) -- Kanzhun Limited (NASDAQ:BZ), which operates China's largest online recruitment platform BOSS Zhipin*, visits the Nasdaq MarketSite in Times Square. Founded in 2014, BOSS Zhipin is a pioneer in introducing a next-generation Direct Recruitment Model which is transforming China's online recruitment industry. The mobile-native product promotes instant direct communication between recruiters and job seekers, delivers accurate matching results through its proprietary recommendation algorithms powering by big data insights. Benefiting from the unique business model and strong technology capability, BOSS Zhipin connects job seekers and enterprise users

6/17/24 10:40:05 AM ET

$BZ

Computer Software: Programming Data Processing

Technology

BOSS Zhipin Repurchases 748,460 Shares; Total Repurchases Amount to Over RMB480 Million in 2026

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$BZ

BOSS Zhipin Repurchases 748,460 Shares; Total Repurchases Amount to Over RMB480 Million in 2026

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$BZ

$BZ
Analyst Ratings

Kanzhun Limited upgraded by UBS with a new price target

Kanzhun Limited downgraded by Bernstein with a new price target

CLSA initiated coverage on Kanzhun Limited with a new price target

$BZ
Press Releases

BOSS Zhipin Repurchases 748,460 Shares; Total Repurchases Amount to Over RMB480 Million in 2026

BOSS Zhipin Continues Share Repurchase Program; Cumulative Repurchases Reach Nearly RMB450 Million in FY26

BOSS Zhipin Continues Share Repurchase Program, Reinforcing Commitment to Shareholder Returns

$BZ
Insider Trading

SEC Form 4 filed by Chen Xu

SEC Form 4 filed by Mu Yang

SEC Form 4 filed by Zhang Kylen Tao

$BZ
SEC Filings

SEC Form 6-K filed by KANZHUN LIMITED

SEC Form 6-K filed by KANZHUN LIMITED

SEC Form 6-K filed by KANZHUN LIMITED

$BZ
Financials

BOSS Zhipin Continues Share Repurchase Program; Cumulative Repurchases Reach Nearly RMB450 Million in FY26

BOSS Zhipin Continues Share Repurchase Program, Reinforcing Commitment to Shareholder Returns

KANZHUN LIMITED Announces Shareholder Return Target Through Dividend Distribution and Extension and Upsizing of Share Repurchase Program

$BZ
Leadership Updates

KANZHUN LIMITED Announces Board Changes and Appointment of President

Allink Biotherapeutics Raises $42M Series A Financing to Accelerate Global Development of Bispecific Antibody and ADC Pipeline

Kanzhun Limited (Nasdaq: BZ) Rings The Nasdaq Stock Market Opening Bell

$BZ
Large Ownership Changes

SEC Form SC 13G/A filed by KANZHUN LIMITED (Amendment)

SEC Form SC 13G/A filed by KANZHUN LIMITED (Amendment)

SEC Form SC 13G/A filed by KANZHUN LIMITED (Amendment)

BOSS Zhipin Repurchases 748,460 Shares; Total Repurchases Amount to Over RMB480 Million in 2026

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $BZ

BOSS Zhipin Repurchases 748,460 Shares; Total Repurchases Amount to Over RMB480 Million in 2026

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $BZ

$BZ Analyst Ratings

Kanzhun Limited upgraded by UBS with a new price target

Kanzhun Limited downgraded by Bernstein with a new price target

CLSA initiated coverage on Kanzhun Limited with a new price target

$BZ Press Releases

BOSS Zhipin Repurchases 748,460 Shares; Total Repurchases Amount to Over RMB480 Million in 2026

BOSS Zhipin Continues Share Repurchase Program; Cumulative Repurchases Reach Nearly RMB450 Million in FY26

BOSS Zhipin Continues Share Repurchase Program, Reinforcing Commitment to Shareholder Returns

$BZ Insider Trading

SEC Form 4 filed by Chen Xu

SEC Form 4 filed by Mu Yang

SEC Form 4 filed by Zhang Kylen Tao

$BZ SEC Filings

SEC Form 6-K filed by KANZHUN LIMITED

SEC Form 6-K filed by KANZHUN LIMITED

SEC Form 6-K filed by KANZHUN LIMITED

$BZ Financials

BOSS Zhipin Continues Share Repurchase Program; Cumulative Repurchases Reach Nearly RMB450 Million in FY26

BOSS Zhipin Continues Share Repurchase Program, Reinforcing Commitment to Shareholder Returns

KANZHUN LIMITED Announces Shareholder Return Target Through Dividend Distribution and Extension and Upsizing of Share Repurchase Program

$BZ Leadership Updates

KANZHUN LIMITED Announces Board Changes and Appointment of President

Allink Biotherapeutics Raises $42M Series A Financing to Accelerate Global Development of Bispecific Antibody and ADC Pipeline

Kanzhun Limited (Nasdaq: BZ) Rings The Nasdaq Stock Market Opening Bell

$BZ Large Ownership Changes

SEC Form SC 13G/A filed by KANZHUN LIMITED (Amendment)

SEC Form SC 13G/A filed by KANZHUN LIMITED (Amendment)

SEC Form SC 13G/A filed by KANZHUN LIMITED (Amendment)

Recent Analyst Ratings for
$BZ

Recent Analyst Ratings for
$BZ

$BZ
Analyst Ratings

$BZ
Press Releases

$BZ
Insider Trading

$BZ
SEC Filings

$BZ
Financials

$BZ
Leadership Updates

$BZ
Large Ownership Changes